刘继斌 - 百度学术

我要认证

刘继斌

3234人看过

ScholarID:CN-BT75Q4MJ

南通市肿瘤医院

被引频次
2836
成果数
192
H指数
27
G指数
50



领域: 临床医学

期刊

91.1%

会议

6.3%

专著

其它

2.6%

总计

192篇

期刊 91.1%(共175篇)

北大核心期刊16

CSCD期刊数4

中国科技核心81

SCI期刊数15

SCIE期刊数33

其他期刊数62

会议论文6.3%(共12篇)

其他会议数12

其它2.6%(共5篇)

2011年成果数22

2015年被引量470

全部年份

全部类型

全部作者

按时间降序

Comprehensive Analysis to Identify DLEU2L/TAOK1 Axis as Prognostic Biomarkers in Hepatocellular Carcinoma

2021 - Yi Shi，Dan-Dan Zhang，Ji-Bin Liu，... - 《Molecular Therapy - Nucleic Acids》 - 被引量: 0

收藏相关文章

Quantitative proteomics characterization of cancer biomarkers and treatment

2021 - Xiao-Li Yang，Yi Shi，Dan-Dan Zhang，... - 《Molecular Therapy — Oncolytics》 - 被引量: 0

收藏相关文章

A miR-212-3p/SLC6A1 Regulatory Sub-Network for the Prognosis of Hepatocellular Carcinoma.

2021 - Dan-Dan Zhang，Wen-Er Wang，Yu-Shui Ma，... - 《Cancer Management and Research》 - 被引量: 0

收藏相关文章

MiR-9-1 Suppresses Cell Proliferation and Promotes Apoptosis by Targeting UHRF1 in Lung Cancer.

2021 - Cheng-You Jia，Wei Xiang，Ji-Bin Liu，... - 《Technology in Cancer Research & Treatment》 - 被引量: 0

收藏相关文章

Exosomal microRNA-15a from mesenchymal stem cells impedes hepatocellular carcinoma progression via downregulation of SALL4

2021 - Yu Shui Ma ，Ji Bin Liu ，Lan Lin ，... - 被引量: 0

收藏相关文章

Targeting Long Non-coding RNA to Therapeutically Regulate Gene Expression in Cancer

2020 - Yu-Shui Ma，Yi Shi，Ji-Bin Liu，... - 《Molecular Therapy - Nucleic Acids》 - 被引量: 0

收藏相关文章

Serotonin-induced miR-221/222 contribute to the activation of hepatic stellate cells

2020 - Yi Xiang，Yu-Shui Ma，Ji-Bin Liu，... - 《Biologia》 - 被引量: 0

收藏相关文章

Power and promise of exosomes as clinical biomarkers and therapeutic vectors for liquid biopsy and cancer control

2020 - Yu-Shui Ma，Xiao-Li Yang，Rui Xin，... - 《Biochimica et Biophysica Acta (BBA) - Reviews on Cancer》 - 被引量: 0

收藏相关文章

Power and Promise of Next-Generation Sequencing in Liquid Biopsies and Cancer Control:

2020 - Ting-Miao Wu，Ji-Bin Liu，Yu Liu，... - 《Cancer control: journal of the Moffitt Cancer Center》 - 被引量: 0

收藏相关文章

New Therapeutic Options for Advanced Hepatocellular Carcinoma

2020 - Yu-Shui Ma，Ji-Bin Liu，Ting-Miao Wu，... - 《Cancer control: journal of the Moffitt Cancer Center》 - 被引量: 0

收藏相关文章

Prognosis for intrahepatic cholangiocarcinoma patients treated with postoperative adjuvant transcatheter hepatic artery chemoembolization

2020 - Ji-Bin Liu，Kai-Jian Chu，Chang-Chun Ling，... - 《Current Problems in Cancer》 - 被引量: 0

收藏相关文章

血清肿瘤标志物联合检测对肺癌的诊断价值观察上

2019 - 徐文平，刘继斌 - 《贵州医药》 - 被引量: 0

收藏相关文章

Long Noncoding RNA OIP5-AS1 Promotes the Progression of Liver Hepatocellular Carcinoma via Regulating miR-26a-3p/EPHA2 Axis

2019 - Yu-Shui Ma，Kai-Jian Chu，Ji-Bin Liu，... - 《SSRN Electronic Journal》 - 被引量: 0

收藏相关文章

HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma

2019 - 《Cancer Medicine》 - 被引量: 0

收藏相关文章

HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma.

2019 - Zijun，Ge，Ting，... - 《Cancer Medicine》 - 被引量: 0

收藏相关文章

In vivoacquired sorafenib-resistant patient-derived tumor model displays alternative angiogenic pathways, multi-drug resistance and chromosome instability

2018 - Hu Gang，Zhang Yixin，Ouyang Kedong，... - 《Oncology Letters》 - 被引量: 0

收藏相关文章

Expression quantitative trait loci for PVT1contributes to the prognosis of hepatocellular carcinoma

2018 - Ting Tian，Ci Song，Zhe-Ning Pu，... - 《肝癌研究(英文版)》 - 被引量: 0

收藏相关文章

Expression quantitative trait loci for PVT1 contributes to the prognosis of hepatocellular carcinoma

2018 - Ting Tian，Ci Song，Zhe-Ning Pu，... - 《肝癌研究:英文版》 - 被引量: 0

收藏相关文章

159株耐碳青霉烯类肠杆菌科细菌的临床特征和耐药性分析

2018 - 张慧，王健，吴晓燕，... - 《检验医学与临床》 - 被引量: 0

收藏相关文章

12345...15

合作机构

南通市肿瘤医院222
南京医科大学公共卫生学院69
南通大学附属肿瘤医院68
江苏省南通市肿瘤医院27
南京医科大学第二附属医院25
江苏省疾病预防控制中心21
启东肝癌防治研究所13
江苏大学医学技术学院12
上海市疾病预防控制中心11
南京医科大学第一附属医院8

期刊 91.1%(共175篇)

会议论文6.3%(共12篇)

其它2.6%(共5篇)

Comprehensive Analysis to Identify DLEU2L/TAOK1 Axis as Prognostic Biomarkers in Hepatocellular Carcinoma

Quantitative proteomics characterization of cancer biomarkers and treatment

A miR-212-3p/SLC6A1 Regulatory Sub-Network for the Prognosis of Hepatocellular Carcinoma.

MiR-9-1 Suppresses Cell Proliferation and Promotes Apoptosis by Targeting UHRF1 in Lung Cancer.

Exosomal microRNA-15a from mesenchymal stem cells impedes hepatocellular carcinoma progression via downregulation of SALL4

Targeting Long Non-coding RNA to Therapeutically Regulate Gene Expression in Cancer

Serotonin-induced miR-221/222 contribute to the activation of hepatic stellate cells

Power and promise of exosomes as clinical biomarkers and therapeutic vectors for liquid biopsy and cancer control

Power and Promise of Next-Generation Sequencing in Liquid Biopsies and Cancer Control:

New Therapeutic Options for Advanced Hepatocellular Carcinoma

Prognosis for intrahepatic cholangiocarcinoma patients treated with postoperative adjuvant transcatheter hepatic artery chemoembolization

血清肿瘤标志物联合检测对肺癌的诊断价值观察上

Long Noncoding RNA OIP5-AS1 Promotes the Progression of Liver Hepatocellular Carcinoma via Regulating miR-26a-3p/EPHA2 Axis

HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma

HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma.

In vivoacquired sorafenib-resistant patient-derived tumor model displays alternative angiogenic pathways, multi-drug resistance and chromosome instability

Expression quantitative trait loci for PVT1contributes to the prognosis of hepatocellular carcinoma

Expression quantitative trait loci for PVT1 contributes to the prognosis of hepatocellular carcinoma

159株耐碳青霉烯类肠杆菌科细菌的临床特征和耐药性分析

更多>>合作学者

合作机构

关于我们

友情链接

联系我们

合作与服务

引用